Multiple Roles of Fibroblast Growth Factor 21 in Metabolism

Author(s): L i Li, Liling Tang

Journal Name: Current Pharmaceutical Design

Volume 21 , Issue 21 , 2015

Become EABM
Become Reviewer


It is necessary to use more effective and safer therapies to treat the increasing prevalence of metabolic diseases. The evidence from several studies indicates that FGF21 which acts as an endocrine hormone can induce beneficial influence to metabolism without apparent adverse effects. Thus, the pharmacologic and physiologic actions of FGF21 play a key role in controlling substrate utilization and energy balance. Recently, the developments in the understanding of FGF21 have contributed to make FGF21 a viable and promising therapeutic agent. This review discusses the functions of FGF21 in the high-fat-diet response, the relationship between exercise and the expression of FGF21, the interaction between FGF21 and some important hormone, the potential of FGF21 pharmacology in human and the methods to prolong the half-life of FGF21. These perspectives about FGF21’s therapeutic potential highlight the importance of this molecule which could be a novel and attractive drug for metabolism disorder.

Keywords: Exercise, fibroblast growth factor 21, half-life, high-fat-diet, hormone, metabolism, pharmacology, therapeutic agent.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2015
Published on: 09 June, 2015
Page: [3041 - 3050]
Pages: 10
DOI: 10.2174/1381612821666150212155239
Price: $65

Article Metrics

PDF: 40